Representative, Reliable and Reproducible in vitro Models of the Human Testes
The project aims to develop a reliable preclinical model of human testes using tailored hydrogels to improve male infertility treatments through high-throughput experimentation and automated analysis.
Projectdetails
Introduction
Western society is on the brink of a fertility crisis, whereby human sperm counts have dropped by 59% over the past four decades and are projected to reach zero by 2045. Treatments for the primary causes of male infertility have no scientific basis, with urologists relying on ineffective empirical medical strategies (guess work).
Need for Preclinical Models
Identifying effective male fertility treatments requires appropriate preclinical models of the sperm-producing testes that can establish a mechanistic basis for treatment choice, dosage, and duration.
Requirements for Models
Preclinical models must:
- Accurately represent the organ-specific tissue
- Be amenable to high-throughput experimentation with automated analysis
- Ensure that they provide representative, reliable, and reproducible data
However, current models necessitate manual low-throughput methods and do not accurately represent testicular tissue as the pertinent tissue properties are unknown. The urological field therefore lacks an appropriate model of the testes upon which to evaluate male infertility treatments.
Proposed Solution
The applicant will address this gap by characterising the relevant properties of human testicular tissue and establishing their effects on resident cell function.
Development of Hydrogel Material
The resulting data will inform the development of a hydrogel material with properties tailored to match those of the native tissue.
Fabrication and Analysis
Microspheres of the representative hydrogel, containing primary testicular cells arranged to mimic the native tissue structure, will be fabricated using a high-throughput platform and analysed using an automated Raman spectroscope. This will form the first representative, reliable, and reproducible model of the human testes.
Validation and Application
The RE3MODEL system will be validated against established in vitro models and used to determine the therapeutic mechanisms of current empirical medical strategies, while also identifying and optimising the most promising treatment approaches as an exemplar application.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.980 |
Totale projectbegroting | € 1.499.980 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITY OF LIMERICKpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Developing a human-based stem cell model for reproductive toxicityDeveloping a high-throughput human-based assay for male reproductive toxicity to enhance drug safety testing and reduce reliance on animal models. | ERC Proof of... | € 150.000 | 2024 | Details |
Shaping the future – From spermatids to spermatozoaThe project aims to enhance understanding of sperm cell morphology and motility through advanced imaging techniques, with implications for infertility diagnosis and potential male contraceptive development. | ERC Consolid... | € 1.999.963 | 2023 | Details |
SAfeguarding female FERtility -development of human-relevant in vitro tools for reproductive toxicitySAFER aims to develop innovative, animal-free assays for assessing reproductive toxicity in women, using advanced technologies to identify harmful chemicals and promote safer environments. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Sperm filtration for improved success rate of assisted reproduction technologyThe 3D nanoMorph project enhances sperm selection for assisted reproduction technologies by enabling detailed analysis of motility and kinematics, addressing fertility challenges in an aging population. | ERC Proof of... | € 150.000 | 2023 | Details |
Towards Artificial Human Embryoid Models: Engineered and Synthetic Platforms for Ex Utero Mammalian EmbryogenesisDevelop biotechnological platforms to culture mammalian embryos ex utero and create synthetic embryoids for advancing stem cell research and disease modeling. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Developing a human-based stem cell model for reproductive toxicity
Developing a high-throughput human-based assay for male reproductive toxicity to enhance drug safety testing and reduce reliance on animal models.
Shaping the future – From spermatids to spermatozoa
The project aims to enhance understanding of sperm cell morphology and motility through advanced imaging techniques, with implications for infertility diagnosis and potential male contraceptive development.
SAfeguarding female FERtility -development of human-relevant in vitro tools for reproductive toxicity
SAFER aims to develop innovative, animal-free assays for assessing reproductive toxicity in women, using advanced technologies to identify harmful chemicals and promote safer environments.
Sperm filtration for improved success rate of assisted reproduction technology
The 3D nanoMorph project enhances sperm selection for assisted reproduction technologies by enabling detailed analysis of motility and kinematics, addressing fertility challenges in an aging population.
Towards Artificial Human Embryoid Models: Engineered and Synthetic Platforms for Ex Utero Mammalian Embryogenesis
Develop biotechnological platforms to culture mammalian embryos ex utero and create synthetic embryoids for advancing stem cell research and disease modeling.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Cultivating hope one star sperm at a timeSpermotile aims to revolutionize male infertility treatment by providing an automated, AI-driven sperm selection platform that enhances ART success rates and reduces costs for clinics and patients. | EIC Transition | € 2.499.906 | 2025 | Details |
Humane mini-breinen voor R&D-toepassingenHet project ontwikkelt een applicatie voor het kweken en analyseren van humane mini-breinen, ter vermindering van dierproeven. | Mkb-innovati... | € 744.000 | 2021 | Details |
Cultivating hope one star sperm at a time
Spermotile aims to revolutionize male infertility treatment by providing an automated, AI-driven sperm selection platform that enhances ART success rates and reduces costs for clinics and patients.
Humane mini-breinen voor R&D-toepassingen
Het project ontwikkelt een applicatie voor het kweken en analyseren van humane mini-breinen, ter vermindering van dierproeven.